Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
Antivir Chem Chemother ; 13(3): 157-64, 2002 May.
Article in English | MEDLINE | ID: mdl-12448688

ABSTRACT

The initial step during hepatitis B virus (HBV) infection is the specific attachment of the virus to the hepatocyte. Here we studied whether the binding of HBV to hepatocytes can, as is the case with most other enveloped viruses, be blocked by polyanionic compounds. Viral particles produced by HepAD38 cells were used as inoculum and HBV-negative HepG2 cells, as well as primary human hepatocytes, as target cells. Three sulphated polymers, that is, PAVAS (a co-polymer of acrylic acid with vinyl alcohol sulphate), heparin and dextran sulphate (DS) (MW 5000), and the sulphonated polymer PAMPS [poly(2-acryl-amido-2-methyl-1-propanesulfonic acid] (MW approximately 7000-12000), proved strong inhibitors of the binding of HBV to HepG2 cells and primary hepatocytes. The 50% effective concentration (EC50) for inhibition of HBV binding to HepG2 cells by PAVAS, heparin, DS and PAMPS was 1.3 microg/ml, 1.6 microg/ml, 1.8 microg/ml and 3.3 microg/ml, respectively, and to primary hepatocytes 1.6 microg/ml (PAVAS), 1.6 microg/ml (heparin), 2.6 microg/ml (DS) and 4.1 microg/ml (PAMPS). These values are in the same range as the concentrations required for these compounds to prevent such viruses as herpesviruses and HIV from binding to cells. These findings may be helpful in elucidating the mechanism of the initial interaction of HBV with hepatocytes.


Subject(s)
Antiviral Agents/pharmacology , Cell Adhesion/drug effects , Hepatitis B virus/drug effects , Hepatitis B virus/physiology , Hepatocytes/drug effects , Hepatocytes/virology , Polymers/chemistry , Polymers/pharmacology , Acrylic Resins/chemistry , Acrylic Resins/pharmacology , Animals , Antiviral Agents/chemistry , CHO Cells , Cells, Cultured , Cricetinae , Dextran Sulfate/chemistry , Dextran Sulfate/pharmacology , Dose-Response Relationship, Drug , Heparin/chemistry , Heparin/pharmacology , Heparin Lyase/metabolism , Humans , Logistic Models , Membrane Proteins/metabolism , Molecular Structure , Protein Binding/drug effects , Sulfonic Acids/chemistry , Sulfonic Acids/pharmacology
2.
Br J Surg ; 89(12): 1540-4, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12445063

ABSTRACT

BACKGROUND: Rectal irrigation with a cytotoxic agent does not kill viable intraluminal cancer cells proximal to the primary tumour. To prevent implantation of these cells at the time of restorative proctectomy, the feasibility of retrograde whole-colon irrigation just before surgery was explored. METHODS: The cytotoxic efficacy of different combinations of povidone-iodine (PVPI) and Gastrografin was tested with the trypan blue exclusion test on a human colon carcinoma cell line (SW620) in vitro. Subsequently, a retrograde whole-colon lavage with PVPI 5 per cent and Gastrografin 12 per cent was performed in 14 euthyroid, non-allergic patients with colorectal cancer using a colostomy irrigation set. Thyroid function and mucosal damage were assessed. RESULTS: It took 2 min and approximately 1 litre of infused solution to reach the caecum in all patients. The solution was 100 per cent tumoricidal in vitro and remained so after colonic irrigation. Total serum tri-iodothyronine (T3) levels decreased and those of reverse T3 increased, but normalized after 1 week. Superficial epithelial desquamation was observed shortly after irrigation; however, complete restoration occurred within 7 days. CONCLUSION: A rectal washout can easily be extended to a retrograde irrigation of the whole colon in elective colorectal cancer surgery. This may help to prevent anastomotic and local recurrence due to implantation of viable exfoliated tumour cells.


Subject(s)
Anti-Infective Agents, Local/administration & dosage , Antibiotics, Antineoplastic/administration & dosage , Colorectal Neoplasms/surgery , Contrast Media , Diatrizoate Meglumine/administration & dosage , Neoplasm Seeding , Povidone-Iodine/administration & dosage , Adult , Aged , Aged, 80 and over , Dose-Response Relationship, Drug , Feasibility Studies , Female , Humans , Male , Middle Aged , Proctocolectomy, Restorative , Therapeutic Irrigation/methods , Tumor Cells, Cultured
4.
J Viral Hepat ; 8(2): 132-8, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11264733

ABSTRACT

Studies on the in vitro hepatitis C virus (HCV) infection are hampered by the lack of an appropriate system to culture permissive cells to be continuously infected with HCV. Trypsinization required for cell passage can lead to possible temporary loss of permissiveness for infection, whereas refreshment of the medium can result in loss of infectious particles necessary for perpetuation of the infection; it is therefore very difficult to maintain a continuous HCV infection in cell cultures. A new infection method was designed and evaluated in order to prevent these unfavourable circumstances. A cell line derived from the human hepatoblastoma cell line Hep G2 was grown in the extracapillary space of a haemodialysis cartridge, in the presence of a HCV-positive inoculum, while the culture medium was recirculated through the intracapillary space, supplying the cells with nutrients and oxygen. HCV RNA could continuously be detected in the cells up to 77 days of culture. Sequence analysis of the HCV hypervariable region 1 (HVR1) revealed that 56% and 75%, respectively, of the clones obtained from the cells at day 20 and 40 after start of the infection were different from the clones obtained from the original inoculum and that certain nucleotide positions in this region were more susceptible to mutations, leading to an alteration in amino acid sequence. As none of these sequences were present in the clones from the inoculum, it is suggested that new HCV quasispecies have emerged as a result of viral replication in the hepatocytes in vitro. This system seems a valuable tool for the in vitro evaluation of antiviral drugs.


Subject(s)
Hepacivirus/genetics , Viral Proteins/genetics , Amino Acid Sequence , Base Sequence , Cell Culture Techniques/methods , Cell Line , Culture Media , Hepacivirus/chemistry , Humans , Molecular Sequence Data , RNA, Viral/analysis , Sequence Analysis, Protein , Time Factors , Viral Proteins/chemistry , Virus Replication
5.
J Viral Hepat ; 7(2): 104-14, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10760040

ABSTRACT

Previously, we have determined that human annexin V (hAV), a Ca2+-dependent phospholipid-binding protein, and not rat AV, binds specifically to small hepatitis B surface antigen (SHBsAg), and that transfection of a rat hepatoma cell line with a construct containing the hAV gene led to hAV expression and conferred susceptibility to hepatitis B virus (HBV) infection. In this work, we have examined the effect of administration of hAV on in vitro binding of SHBsAg to human and to rat hepatocytes and on in vitro HBV infection. The results showed that hAV could bind to human as well as to rat hepatocytes. Because of this property, excess hAV was unable to prevent HBV infection in primary cultures of human hepatocytes. On the other hand, it enabled rat hepatocytes to specifically bind SHBsAg and conferred susceptibility to HBV infection. After infection of primary cultures of rat hepatocytes in the presence of hAV, HBV mRNA, covalently closed circular (ccc) DNA, replicative intermediates, hepatitis B surface antigen (HBsAg), hepatitis B core antigen (HBcAg) and secreted HBV DNA were detected. After infection in the absence of hAV, no markers of HBV replication were detected. Hence, from the present study we conclude that hAV is involved in facilitating HBV entry, leading to successful HBV infection in primary cultures of rat hepatocytes, while it is not effective in preventing HBV infection in primary cultures of human hepatocytes.


Subject(s)
Annexin A5/pharmacology , Hepatitis B Surface Antigens/metabolism , Hepatitis B virus/physiology , Liver/metabolism , Animals , Cells, Cultured , Cryopreservation , Disease Susceptibility , Hepatitis B/metabolism , Hepatitis B/prevention & control , Hepatitis B virus/drug effects , Humans , Liver/cytology , Liver/drug effects , Liver/virology , Protein Binding/drug effects , Rats , Rats, Wistar
6.
Biopharm Drug Dispos ; 21(9): 353-64, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11523064

ABSTRACT

Six 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (the present cholesterol-lowering drugs known as statins), lovastatin (L), simvastatin (S), pravastatin (P), fluvastatin (F), atorvastatin (A) and cerivastatin (C) are shown to be potent inhibitors of cholesterol synthesis in human hepatocytes, the target tissue for these drugs in man. All six inhibited in the nM range (IC(50) values: 0.2-8.0 nM). As daily used cholesterol-lowering drugs they are likely coadministered with other drugs. While several cytochrome P450 (CYP) enzymes are involved in drug metabolism in the liver and thus play an important role in drug-drug interaction it was investigated which of these enzymes are influenced by the active forms of the six statins. These enzyme activities were studied in human liver microsomal preparations, and in simian and human hepatocytes in primary culture. The following CYP reactions were used: nifedipine aromatization (CYP3A4), testosterone 6beta-hydroxylation (CYP3A4), tolbutamide methylhydroxylation (CYP2C9), S-mephenytoin 4-hydroxylation (CYP2C19), bufuralol 1'-hydroxylation (CYP2D6), aniline 4-hydroxylation (CYP2E1), coumarin 7-hydroxylation (CYP2A6) and 7-ethoxyresorufin O-dealkylation (CYP1A1/2). In the human liver microsomes the statins (concentrations up to 400 microM) did not influence the CYP1A1/2 activity and hardly the CYP2A6 and CYP2E1 activities. Except P, the other five statins were stronger inhibitors of the CYP2C19 activity with IC(50) values around 200 microM and the same holds for the effect of A, C and F on the CYP2D6 activity. L and S were weaker inhibitors of the latter enzyme activity, whereas P did not influence both activities. About the same was observed for the statin effect on CYP2C9 activity, except that F was a strong inhibitor of this activity (IC(50) value: 4 microM). Using the assay of testosterone 6beta-hydroxylation the CYP3A4 activity was decreased by L, S and F with IC(50) values of about 200 microM and a little more by C and A (IC(50) around 100 microM). P had hardly an effect on this activity. To a somewhat less extent the same trend was seen when CYP3A4 activity was measured using nifedipine as substrate. The inhibitory effects observed in microsomes were verified in suspension culture of freshly isolated hepatocytes from Cynomolgus monkey (as a readily available model) and of human hepatocytes. In general the same trends were seen as in the human microsomes, except that in some cases the inhibition of the CYP activity was less, possibly by the induction of the particular CYP enzyme by incubation of the cells with a particular statin. F remained a strong inhibitor of CYP2C9 activity in human and monkey hepatocytes. A induced the CYP2C9 in monkey hepatocytes but was an inhibitor of the CYP2C9 in human hepatocytes. A, S, L and C were moderate inhibitors in both cellular systems of CYP3A4. P was not affecting any of the CYP activities in the three systems studied. It is concluded that different CYP enzymes interact with different statins and therefore differences in between these drugs are to be expected when drug-drug interaction is considered.


Subject(s)
Cholesterol/biosynthesis , Cytochrome P-450 Enzyme System/drug effects , Hepatocytes/enzymology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Animals , Cytochrome P-450 Enzyme Inhibitors , Cytochrome P-450 Enzyme System/metabolism , Drug Interactions , Hepatocytes/drug effects , Humans , Macaca fascicularis
7.
J Viral Hepat ; 5(6): 377-87, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9857347

ABSTRACT

Studies on the pathobiology of chronic (long-term) hepatitis B virus (HBV) infection and in vitro drug testing have been hampered by the lack of appropriate systems for culturing susceptible cells chronically infected with HBV. Most of the in vitro studies of HBV replication have been performed with HBV genome-transduced cell lines. In this system, viral production is mainly the result of chromosomal replication. In an in vitro infection system, owing to medium refreshment (which leads to the removal of infectious particles necessary for the perpetuation of infection) and to trypsinization for cell passages, it is difficult, if not impossible, to maintain chronic HBV infection, despite the use of susceptible cells. To circumvent these unfavourable factors for chronic HBV infection in vitro, we cultured microcarrier-attached immortalized human hepatocytes, infected with HBV, in molecularporous (MW 12,000-14,000) membrane (dialysis) bags for a duration of 2 months. HBV covalently-closed-circular (ccc) DNA, HBV precore/core and X mRNAs were detected in the cells cultured in this system following infection until the end of the experiment (day 58), while in classical culture conditions (monolayer), markers of HBV replication were also detected. Production of hepatitis B surface antigen (HBsAg) and HBV DNA was detected and their levels in culture medium (collected at the end of experiments from the molecularporous membrane bags) were increased 2.86- and 3.28-fold respectively. Using Southern blot analysis, HBV replicative intermediates could also be demonstrated throughout the experiments. However, integrated HBV DNA was not present. In contrast, HBV ccc DNA, HBV precore/core and X mRNAs, and replicative intermediates were not demonstrable in FTO 2B rat hepatoma cells infected in the same manner in parallel experiments. This in vitro infection system, using susceptible, immortalized human hepatocytes, therefore provides a new tool for studying the long-term effect of HBV infection, mainly involving episomal replication in hepatocytes, and for drug testing.


Subject(s)
Hepatitis B virus/physiology , Hepatitis B, Chronic/physiopathology , Liver/cytology , Virus Replication , Blotting, Southern , Capsules , Cells, Cultured , Cells, Immobilized , Culture Media , DNA, Circular/analysis , DNA, Viral/analysis , Hepatitis B Core Antigens/biosynthesis , Hepatitis B Surface Antigens/biosynthesis , Humans , Immunohistochemistry , Liver/metabolism , RNA, Messenger/analysis , RNA, Viral/analysis , Reverse Transcriptase Polymerase Chain Reaction/methods , Virology/methods
8.
J Hepatol ; 27(4): 688-98, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9365045

ABSTRACT

BACKGROUND/AIMS: In a previous study, we have demonstrated that primary human hepatocytes in culture are susceptible for Plasmodium falciparum sporozoite invasion and for development of parasites into exo-erythrocytic forms. In a separate study we demonstrated the involvement of two human liver plasma membrane proteins (55 kD and 20 kD) in the invasion of P. falciparum sporozoites in vitro. In this study, we have unravelled the nature of the 55 kD protein. METHODS: For the identification of this protein, a 53-58 kD membrane protein fraction from human liver was isolated, radioactively labelled, incubated with sporozoites and cross-linked. After reduction of the cross-linker, the released proteins were mixed with unlabelled 53-58 kD protein fraction and separated on two-dimensional SDS-PAGE. Autoradiography showed a single spot corresponding to a protein of 55 kD and pI of 5.7-5.8. RESULTS: Amino acid sequencing revealed the 55 kD protein as carboxylesterase. The biological activity of purified human liver carboxylesterase and of an antiserum against carboxylesterase on sporozoite invasion in vitro was evaluated. Human carboxylesterase as well as a rabbit antiserum against carboxylesterase inhibited the invasion of P. falciparum sporozoites into primary human hepatocytes in culture. A number of carboxylesterase cDNA clones were isolated from a human liver cDNA library. Sequence analysis revealed two different iso-types. Immunoaffinity purified recombinant human carboxylesterase was shown also to inhibit the invasion of sporozoites into primary human hepatocytes. Immunocytochemical analysis of the localisation of carboxylesterase in primary cultures of human hepatocytes using specific antibodies, showed its presence inside the hepatocytes and on the membrane. CONCLUSIONS: Carboxylesterase plays a role in the invasion process of P. falciparum sporozoites into human hepatocytes in vitro. The implications of these findings are further discussed.


Subject(s)
Carboxylic Ester Hydrolases/analysis , Liver/enzymology , Liver/parasitology , Malaria, Falciparum/enzymology , Plasmodium falciparum/pathogenicity , Protozoan Proteins/analysis , Amino Acid Sequence , Animals , Carboxylic Ester Hydrolases/genetics , Cells, Cultured , Humans , Immunohistochemistry , Liver/cytology , Molecular Sequence Data , Molecular Weight , Plasmodium falciparum/physiology , Protein Binding , Protozoan Proteins/genetics
9.
Differentiation ; 59(4): 253-8, 1995 Nov.
Article in English | MEDLINE | ID: mdl-8575647

ABSTRACT

The expression and cellular distribution of desmin, alpha-smooth muscle actin (A-SMA) and cytokeratin no. 8 (CK-8) and no. 18 (CK-18) in normal adult, neonatal and fetal rat liver were examined immunohistochemically on cryostat sections. At days 14 and 15 of gestation, nonhematopoietic cells in embryonic liver were strongly desmin-positive, and some of the cells, mainly located in the periphery, were also stained with anti-A-SMA. Desmin immunoreactivity gradually decreased from day 16 of gestation. A close association of desmin-positive cell processes with hematopoietic cells was observed during fetal and early neonatal development. From day 16 of gestation the pre-hepatocytes became desmin-negative, remained CK-8 and CK-18 positive. Desmin-expressing cells were numerous in the liver from the embryonic period to the neonatal age. However, their absolute number per unit area, as well as their number relative to hepatocytes, decreased with age. We suggest that desmin-positive cells in embryonic liver may act as stromal cells in the hepatic hematopoietic microenvironment and support hepatocyte development.


Subject(s)
Actins/analysis , Desmin/analysis , Liver/chemistry , Animals , Embryonic and Fetal Development/physiology , Hematopoietic Stem Cells/chemistry , Immunohistochemistry , Keratins/analysis , Liver/anatomy & histology , Liver/growth & development , Rats , Rats, Inbred Strains
10.
Mol Biochem Parasitol ; 72(1-2): 179-92, 1995 Jun.
Article in English | MEDLINE | ID: mdl-8538688

ABSTRACT

Pfs16 is a sexual stage/sporozoite-specific antigen of Plasmodium falciparum and is a potential candidate for a sporozoite-neutralizing vaccine. To obtain more information on the function of Pfs16 and to investigate its role during transmission and hepatocyte invasion, immunization experiments were performed with both a Pfs16-specific recombinant vaccinia virus and virus-like particles produced in yeast composed of the hepatitis B surface antigen (HBsAg) and antigen Pfs16 fused to HBsAg. Upon transformation of yeast cells, harbouring a genomic copy of the HBsAg gene, with a plasmid carrying the fusion gene Pfs16-HBsAg (Pfs16-S) virus-like hybrid particles composed of HBsAg and Pfs16-S were formed of a size similar to those present in human sera after infection with the hepatitis B virus. Cells infected with recombinant Pfs16 vaccinia virus synthesized a polypeptide of approx. 16 kDa that reacted with a Pfs16-specific polyclonal antibody. Animals vaccinated with the yeast hybrid particles and/or recombinant vaccinia virus both produced Pfs16-specific antibodies. These antibodies showed no transmission-blocking activity, but they efficiently diminished or abolished in vitro invasion of sporozoites into human hepatoma cells (HepG2-A16) and primary human hepatocytes.


Subject(s)
Antibodies, Protozoan/biosynthesis , Antigens, Protozoan/immunology , Malaria Vaccines/immunology , Membrane Proteins/immunology , Plasmodium falciparum/immunology , Recombinant Fusion Proteins/immunology , Saccharomyces cerevisiae/metabolism , Vaccines, Synthetic/immunology , Vaccinia virus/genetics , Amino Acid Sequence , Animals , Anopheles/parasitology , Antibodies, Protozoan/immunology , Antibody Specificity , Antigens, Protozoan/administration & dosage , Carcinoma, Hepatocellular/pathology , Cells, Cultured , Female , Hepatitis B Surface Antigens/genetics , Hepatitis B Surface Antigens/immunology , Humans , Insect Vectors/parasitology , Liver/cytology , Liver Neoplasms/pathology , Membrane Proteins/administration & dosage , Mice , Molecular Sequence Data , Plasmodium falciparum/genetics , Plasmodium falciparum/growth & development , Rabbits , Tumor Cells, Cultured
11.
J Parasitol ; 80(3): 414-20, 1994 Jun.
Article in English | MEDLINE | ID: mdl-8195943

ABSTRACT

An enzyme-linked immunosorbent assay (ELISA) detecting a Plasmodium berghei liver-stage-specific protein Pbl-1 is described. The quantitative detection limits ranged from 0.01 to 0.05 microgram of parasite protein. Qualitatively the assay detected as little as 0.001 microgram Pbl-1 per well. Using the ELISA dexamethasone and insulin together was shown to promote higher parasite infections in HepG2 cells compared to unsupplemented medium. Anti-cowpea-protease cysteine inhibitor significantly increased hepatocyte invasion as compared to controls, whereas a significant decrease was recorded in the presence of the protease inhibitor E64. Partial involvement of cysteine proteases in HepG2 invasion by P. berghei sporozoites is therefore suggested.


Subject(s)
Cysteine Proteinase Inhibitors/pharmacology , Dexamethasone/pharmacology , Insulin/pharmacology , Plasmodium berghei/physiology , Animals , Cell Line , Cysteine Endopeptidases/physiology , Enzyme-Linked Immunosorbent Assay , Fluorescent Antibody Technique , Liver/parasitology , Plasmodium berghei/drug effects , Plasmodium berghei/growth & development , Protozoan Proteins/analysis , Protozoan Proteins/immunology , Recombinant Fusion Proteins/analysis , Recombinant Fusion Proteins/immunology
13.
Mol Biochem Parasitol ; 44(2): 225-32, 1991 Feb.
Article in English | MEDLINE | ID: mdl-2052023

ABSTRACT

To determine whether surface proteins of hepatocytes might be involved in the sporozoite invasion, plasma membrane proteins were prepared from human livers with CHAPS (3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulphonate) and radiolabelled with 125I (Iodogen; 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenylglycoluril). The labelled proteins were incubated with Plasmodium falciparum sporozoites and cross-linked with DSP (dithio-bis-succinimidylpropionate). Radiolabelled proteins released by reduction after repeated washing of the sporozoite-complex were separated by SDS-PAGE and autoradiographed. Two human hepatocyte membrane proteins of 20 and 55 kDa were found to be involved in the initial binding of P. falciparum sporozoites. The electrophoretically purified 20- and 55-kDa proteins both inhibited the binding of the corresponding radiolabelled proteins to P. falciparum sporozoites and reduced the invasion of sporozoites in an in vitro assay. We propose that these 20-kDa and 55-kDa proteins represent putative human hepatocyte receptors for P. falciparum sporozoite invasion.


Subject(s)
Liver/metabolism , Membrane Proteins/metabolism , Plasmodium falciparum/metabolism , Animals , Cholic Acids , Cross-Linking Reagents , Detergents , Electrophoresis, Polyacrylamide Gel , Humans , Liver/cytology , Liver/parasitology , Membrane Proteins/isolation & purification , Molecular Weight
14.
Biochem Pharmacol ; 40(3): 521-8, 1990 Aug 01.
Article in English | MEDLINE | ID: mdl-2383284

ABSTRACT

The peroxisome-proliferating effects of clofibric acid and beclobric acid were studied in primary cultures of hepatocytes derived from rat, monkey (Macaca fascicularis) and human liver. Determination of peroxisomal fatty acid beta-oxidation and morphometrical analysis of the peroxisomal compartment were performed after incubation of 1-day-old hepatocyte cultures for 3 days with either compound. In rat liver cell cultures both compounds gave a 10-fold increase in peroxisomal beta-oxidation, a 3-fold increase in the relative number of peroxisomes and a 1.5-fold increase in the mean size of peroxisomes. Beclobric acid gave its maximal effect at a concentration of 10 microM, which is at least one order of magnitude lower than the maximum-effect concentration of clofibric acid. At concentrations greater than 300 microM beclobric acid was cytotoxic. No stimulation of peroxisomal fatty acid beta-oxidation was found in either monkey or human hepatocyte cultures. Morphometrical analysis also showed no increase in the peroxisomal compartment in cultures derived from these species, as indicated by the lack of increase in both relative number and size of peroxisomes. In all three species tested beclobric acid was equally cytotoxic for hepatocytes in vitro. These results are of relevance for the interpretation of the peroxisome-proliferating effects of clofibrate and similar compounds in rats. Since peroxisome proliferation may be correlated to increased hepatic tumour incidences in the rat, the absence of peroxisome proliferation in primates suggests the absence of tumourogenic activity by hypolipidemic compounds in these species.


Subject(s)
Benzhydryl Compounds/pharmacology , Clofibrate/analogs & derivatives , Clofibric Acid/pharmacology , Fatty Acids/metabolism , Hypolipidemic Agents/pharmacology , Liver/ultrastructure , Microbodies/metabolism , Adult , Animals , Cells, Cultured , Female , Humans , Macaca fascicularis , Male , Microbodies/drug effects , Microbodies/ultrastructure , Microscopy, Electron , Oxidation-Reduction , Rats , Rats, Inbred Strains
15.
Biochim Biophys Acta ; 950(3): 450-4, 1988 Sep 07.
Article in English | MEDLINE | ID: mdl-3167063

ABSTRACT

During acute inflammation or after administration of monocytic products, an enhanced transcription of the fibrinogen polypeptide genes and a reduced transcription of the albumin gene were observed. The changes in the fibrinogen polypeptide transcriptional rate were found to precede the change in albumin gene transcription. These findings indicate that the altered synthesis of fibrinogen and albumin during inflammation are regulated at the transcriptional level and are most probably mediated by monocytic products (including interleukin-1).


Subject(s)
Fibrinogen/genetics , Gene Expression Regulation , Genes , Liver/metabolism , Serum Albumin/genetics , Transcription, Genetic , Animals , Cell Nucleus/metabolism , Fibrinogen/biosynthesis , Gene Expression Regulation/drug effects , Genes/drug effects , Liver/drug effects , Male , Rats , Rats, Inbred Strains , Serum Albumin/biosynthesis , Transcription, Genetic/drug effects , Turpentine/toxicity
16.
Biochem Biophys Res Commun ; 155(1): 112-7, 1988 Aug 30.
Article in English | MEDLINE | ID: mdl-3261980

ABSTRACT

During the acute phase response, synthesis of C-reactive protein and serum amyloid A is increased. To investigate whether the enhanced synthesis of these proteins are due to stimulatory effect of inflammatory mediators such as interleukin-1 (IL-1) and interleukin-6 (IL-6) produced by macrophages and monocytes, primary cultures of adult human hepatocytes were exposed to recombinant (r)IL-1, rIL-6 or rIL-1 and monospecific anti rIL-6 antibodies in the presence of 1 microM dexamethasone. The findings indicate that rIL-1 and rIL-6 both stimulate the liver synthesis of C-reactive protein and serum amyloid A, however monospecific anti rIL-6 antibodies reduce the stimulatory effect of rIL-1 on the synthesis of these proteins. These findings suggest that IL-6 plays a key role in the stimulation of synthesis of serum amyloid A and C-reactive protein by the human liver cells.


Subject(s)
C-Reactive Protein/biosynthesis , Interleukin-1/pharmacology , Interleukins/pharmacology , Liver/metabolism , Serum Amyloid A Protein/biosynthesis , Adolescent , Adult , Albumins/biosynthesis , Cells, Cultured , Dexamethasone/pharmacology , Humans , Immune Sera/pharmacology , Interleukin-6 , Interleukins/immunology , Liver/cytology , Middle Aged , Recombinant Proteins/immunology , Recombinant Proteins/pharmacology
17.
Clin Sci (Lond) ; 74(5): 477-83, 1988 May.
Article in English | MEDLINE | ID: mdl-3259488

ABSTRACT

1. Monocytic products, especially interleukin-1 (IL-1), play an important role in the acute-phase response. Prostaglandins have been shown to act as second messengers in several physiological alterations of the acute-phase response, such as fever, muscle wasting and immunoregulation. The present study was undertaken to determine the role of prostaglandins in the monocytic-product-induced stimulation of the hepatic synthesis of fibrinogen, a well-known acute-phase protein. 2. Prostaglandin (PG) E2, PGF2 alpha and 16,16-dimethyl-PGE2 did not stimulate fibrinogen synthesis and fibrinogen polypeptide mRNA content when administered intraperitoneally to rats or when added to monolayer cultures of rat hepatocytes. 3. Cyclo-oxygenase inhibitors did not abolish the stimulation of fibrinogen synthesis and its mRNA content induced by monocytic products in vivo or in vitro. 4. These findings indicate that the enhanced synthesis of fibrinogen induced by monocytic products (including IL-1) during the acute-phase response is not mediated by prostaglandins or other products of the cyclo-oxygenase pathway of arachidonic acid.


Subject(s)
Fibrinogen/biosynthesis , Interleukin-1/pharmacology , Liver/metabolism , Prostaglandins E/pharmacology , Prostaglandins F/pharmacology , Animals , Cells, Cultured , Dinoprost , Dinoprostone , Fibrinogen/blood , Male , Prostaglandins/physiology , RNA, Messenger/analysis , Rats , Rats, Inbred Strains
18.
Clin Genet ; 10(5): 273-8, 1976 Nov.
Article in English | MEDLINE | ID: mdl-825332

ABSTRACT

In two related Sanfilippo B families, comprising 27 individuals, some biochemical parameters were studied. After detection of the patients, an attempt was made to distinguish between heterozygotes and normals. The excretion of glycosaminoglycans in the urine and N-acetyl-alpha-D-glucosaminidase activity in leukocytes and plasma were taken as parameters for the study. The determination of N-acetyl-a-D-glucosaminidase activity in plasma is considered to be the most suitable method for heterozygote detection.


Subject(s)
Mucopolysaccharidoses/genetics , Mucopolysaccharidosis III/genetics , Acetylglucosaminidase/blood , Adolescent , Adult , Child , Female , Glycosaminoglycans/urine , Humans , Leukocytes/enzymology , Male , Middle Aged , Mucopolysaccharidosis III/enzymology , Mucopolysaccharidosis III/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...